European Commission Approves Novartis Lung Cancer Drug Zykadia Swiss drug manufacturer Novartis announced that the European Commission has approved Zykadia (ceritinib), a drug used to treat patients suffering from an advanced form of non-small cell lung cancer. by Ted Ranosa